Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Jan;72(1):49–54. doi: 10.1111/j.1476-5381.1981.tb09103.x

Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.

M J Daly, J M Humphray, R Stables
PMCID: PMC2071551  PMID: 6112034

Abstract

1 Ranitidine has been investigated as an antagonist of the H2-receptor-mediated responses to histamine of guniea-pig atrium and rat uterus in vitro and as an inhibitor of gastric acid secretion in the rat. 2 Ranitidine competitively antagonized histamine-induced increases in contraction frequency of the guinea-pig isolated rat atrium. Ranitidine had a pA2 of 7.2 and was 7.9 and 4.5 times more potent than metiamide and cimetidine respectively. 3 Ranitidine competitively antagonized histamine-induced relaxations of the rat isolated uterine horn. Ranitidine had a pA2 of 6.95 and was 3.6 and 5.9 times more potent than metiamide and cimetidine respectively. 4 Ranitidine, even at high concentrations, did not affect responses of the guinea-pig isolated atrium or rat isolated uterus to (-)-isoprenaline. Similarly it was without effect on either histamine or bethanechol-induced contractions of guinea-pig isolated ileum. 5 Ranitidine inhibited histamine- and pentagastrin-induced gastric acid secretion in the perfused stomach preparation of the anaesthetized rat. Ranitidine was 5.2 and 7.0 times more potent on a molar basis than metiamide and cimetidine respectively, as an inhibitor of histamine-induced gastric acid secretion. 6 It is concluded that ranitidine is a potent, competitive and selective antagonist of histamine at H2-receptor sites and and effective inhibitor of gastric acid secretion in vivo.

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ash A. S., Schild H. O. Receptors mediating some actions of histamine. Br J Pharmacol Chemother. 1966 Aug;27(2):427–439. doi: 10.1111/j.1476-5381.1966.tb01674.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  4. Black J. W., Duncan W. A., Emmett J. C., Ganellin C. R., Hesselbo T., Parsons M. E., Wyllie J. H. Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions. 1973 Oct;3(3):133–137. doi: 10.1007/BF01965723. [DOI] [PubMed] [Google Scholar]
  5. Bradshaw J., Brittain R. T., Clitherow J. W., Daly M. J., Jack D., Price B. J., Stables R. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br J Pharmacol. 1979 Jul;66(3):464P–464P. [PMC free article] [PubMed] [Google Scholar]
  6. Brimblecombe R. W., Duncan W. A., Owen D. A., Parsons M. E. The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists. Fed Proc. 1976 Jun;35(8):1931–1934. [PubMed] [Google Scholar]
  7. Carlson H. E., Ippoliti A. F. Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man. J Clin Endocrinol Metab. 1977 Aug;45(2):367–370. doi: 10.1210/jcem-45-2-367. [DOI] [PubMed] [Google Scholar]
  8. Forrest J. A., Shearman D. J., Spence R., Celestin L. R. Letter: Neutropenia associated with metiamide. Lancet. 1975 Feb 15;1(7903):392–393. doi: 10.1016/s0140-6736(75)91305-7. [DOI] [PubMed] [Google Scholar]
  9. Funder J. W., Mercer J. E. Cimetidine, a histamine H2 receptor antagonist, occupies androgen receptors. J Clin Endocrinol Metab. 1979 Feb;48(2):189–191. doi: 10.1210/jcem-48-2-189. [DOI] [PubMed] [Google Scholar]
  10. GHOSH M. N., SCHILD H. O. Continuous recording of acid gastric secretion in the rat. Br J Pharmacol Chemother. 1958 Mar;13(1):54–61. doi: 10.1111/j.1476-5381.1958.tb00190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ganellin C. R., Durant G. J., Emmett J. C. Some chemical aspects of histamine H2-receptor antagonists. Fed Proc. 1976 Jun;35(8):1924–1930. [PubMed] [Google Scholar]
  12. Owen D. A. Histamine receptors in the cardiovascular. Gen Pharmacol. 1977;8(3):141–156. doi: 10.1016/0306-3623(77)90043-x. [DOI] [PubMed] [Google Scholar]
  13. Peden N. R., Saunders J. H., Wormsley K. G. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist. Lancet. 1979 Mar 31;1(8118):690–692. doi: 10.1016/s0140-6736(79)91146-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES